Sarcoma News

A promising new blood test could help doctors spot when osteosarcoma is coming back. Because osteosarcoma has a highly chaotic

Rice University bioengineer Dr. Julea Vlassakis has been awarded a $1.1 million federal grant to advance her research into Ewing

The US Food and Drug Administration (FDA) has granted full approval to a cutting-edge cancer medication called Tecelra and expanded

This study published in Translational Oncology explores new drug combinations to treat Ewing Sarcoma. Traditional treatments are often ineffective for

Pediatric sarcomas are notoriously difficult to treat because they lack precise, molecularly targeted therapies. In this study, scientists discovered that

A major scientific breakthrough in rare cancer research was recently made possible by a family’s generous donation. Jim Hindley and

The Food and Drug Administration (FDA) has agreed to review a new drug called Ozekibart to treat a rare and

A new blood-based test could help doctors better predict treatment success and disease progression in patients with Ewing Sarcoma. Researchers

A major step forward has been made in immunotherapy, specifically focusing on a cancer treatment strategy called the “CD47-SIRPα axis.”

A new position statement from the American Society of Clinical Oncology (ASCO) is aimed at making it easier for children